Michael Nedelcovych
Stock Analyst at TD Cowen
(1.03)
# 3,785
Out of 4,478 analysts
89
Total ratings
44.6%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by Michael Nedelcovych
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $40.00 | $34.62 | +15.54% | 1 | Jul 6, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | $42 | $49.56 | -15.25% | 31 | Jun 29, 2026 | |
| TAK Takeda Pharmaceutical Company | Maintained: Buy | $21 | $16.97 | +23.75% | 14 | Jun 4, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $227 → $250 | $267.25 | -6.45% | 3 | May 29, 2026 | |
| CHRS Coherus Oncology | Maintained: Buy | n/a | $1.68 | - | 13 | May 28, 2026 | |
| RPRX Royalty Pharma | Maintained: Buy | $55 → $50 | $57.78 | -13.46% | 9 | May 6, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | $9.94 | $7.00 | +42.00% | 9 | Apr 30, 2026 | |
| SWX: MOLN Molecular Partners AG | Maintained: Buy | CHF 15.00 | $3.23 | +364.40% | 6 | Mar 16, 2026 | |
| TYO: 4502 Takeda Pharmaceutical Company Limited | Maintained: Buy | ¥5,135 | $5,448.00 | n/a | 1 | May 21, 2025 | |
| MOLN Molecular Partners AG | Maintained: Buy | $17 | $4.07 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥6,550 | $2,719.00 | n/a | 1 | Sep 9, 2024 |
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40.00
Current: $34.62
Upside: +15.54%
Novo Nordisk
Jun 29, 2026
Maintained: Hold
Price Target: $42
Current: $49.56
Upside: -15.25%
Takeda Pharmaceutical Company
Jun 4, 2026
Maintained: Buy
Price Target: $21
Current: $16.97
Upside: +23.75%
Johnson & Johnson
May 29, 2026
Maintained: Buy
Price Target: $227 → $250
Current: $267.25
Upside: -6.45%
Coherus Oncology
May 28, 2026
Maintained: Buy
Price Target: n/a
Current: $1.68
Upside: -
Royalty Pharma
May 6, 2026
Maintained: Buy
Price Target: $55 → $50
Current: $57.78
Upside: -13.46%
Bausch Health Companies Inc.
Apr 30, 2026
Maintained: Hold
Price Target: $9.94
Current: $7.00
Upside: +42.00%
Molecular Partners AG
Mar 16, 2026
Maintained: Buy
Price Target: CHF 15.00
Current: $3.23
Upside: +364.40%
Takeda Pharmaceutical Company Limited
May 21, 2025
Maintained: Buy
Price Target: ¥5,135
Current: $5,448.00
Upside: n/a
Molecular Partners AG
Mar 14, 2025
Maintained: Buy
Price Target: $17
Current: $4.07
Upside: n/a
Sep 9, 2024
Maintained: Buy
Price Target: ¥6,550
Current: $2,719.00
Upside: n/a